Edouard Nicaise

ORCID: 0009-0002-4885-3144
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal cell carcinoma treatment
  • Bladder and Urothelial Cancer Treatments
  • Prostate Cancer Diagnosis and Treatment
  • Renal and related cancers
  • Radiomics and Machine Learning in Medical Imaging
  • Multiple and Secondary Primary Cancers
  • Chronic Kidney Disease and Diabetes
  • Pancreatic and Hepatic Oncology Research
  • Urological Disorders and Treatments
  • Cancer Genomics and Diagnostics
  • MRI in cancer diagnosis
  • Prostate Cancer Treatment and Research
  • Gastrointestinal Tumor Research and Treatment
  • Nutrition and Health in Aging
  • Pediatric Urology and Nephrology Studies
  • Cancer Diagnosis and Treatment
  • Urinary Bladder and Prostate Research
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cancer and Skin Lesions
  • Molecular Biology Techniques and Applications
  • Cancer survivorship and care
  • Pelvic floor disorders treatments
  • Birth, Development, and Health
  • Muscle and Compartmental Disorders
  • Infectious Disease Case Reports and Treatments

Emory University
2023-2025

Massachusetts General Hospital
2019-2024

Emory University Hospital
2024

Johns Hopkins Medicine
2023

Johns Hopkins University
2023

Harvard University
2022

Délégation Paris 6
1893

No AccessJournal of UrologyAdult Urology1 Nov 2019Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Biopsy Improves but Does Not Replace Standard Template for the Detection Prostate CancerThis article is commented on by following:Editorial Comment Nawar Hanna, Matthew F. Wszolek, Amirkasra Mojtahed, Edouard Nicaise, Bo Wu, Francisco J. Gelpi-Hammerschmidt, Keyan Salari, Douglas M. Dahl, Michael L. Blute, Mukesh Harisinghani, and Adam S. Feldman HannaNawar Hanna Department Urology,...

10.1097/ju.0000000000000359 article EN The Journal of Urology 2019-05-30

Abstract Introduction Low creatinine to cystatin-C ratio (Cr/Cys-C) may be a biomarker for low-muscle mass. Furthermore, low Cr/Cys-C is associated with decreased overall survival (OS), but date, has not been examined in patients renal cell carcinoma (RCC). Our objective evaluate associations between and OS recurrence-free (RFS) RCC treated nephrectomy. Methods We performed retrospective review of Patients end-stage disease less than 1-year follow up were excluded. was dichotomized at the...

10.1093/oncolo/oyad218 article EN cc-by The Oncologist 2023-08-04

Abstract Purpose To analyze surgical and oncologic outcomes of patients undergoing open partial nephrectomy (OPN) versus laparoscopic (LPN) for treatment renal cell carcinoma (RCC). Methods We retrospectively investigated our institutional RCC database who underwent PN from 1997 to 2018. Decision technique was at the discretion operating urologist, following practice patterns training history. Outcomes analyzed included pre/peri/post-operative parameters, pathologic outcomes, disease...

10.1186/s12894-024-01423-w article EN cc-by BMC Urology 2024-03-12

565 Background: β2 microglobulin is a nonglycosylated protein synthesized by all nucleated cells. It has been utilized as tumor marker in several different malignancies, however, studies examining its role renal cell carcinoma (RCC) are limited. Methods: Using the Emory kidney cancer database, patients with any stage or histology RCC who underwent partial radical nephrectomy from 2000 to 2022 and had an available within 90 days before surgery were included. ≥ 2.34 mg/L was considered...

10.1200/jco.2025.43.5_suppl.565 article EN Journal of Clinical Oncology 2025-02-10

Background: Transurethral resection of the prostate (TURP) is gold-standard treatment for benign prostatic hyperplasia (BPH). However, laser surgery techniques (e.g., photoselective vaporization (PVP), holmium laser, thulium enucleation (HoLEP or ThuLEP)), and minimally invasive options UroLift) are increasingly replacing TURP. This study seeks to report annual incidence, management trends, costs BPH procedures in U.S. Methods: Data analyses health insurance claims from 2004 2017, collected...

10.3390/app12178697 article EN cc-by Applied Sciences 2022-08-30

A man aged 41 years who had a past medical history significant for bilateral lower extremity varicosities and prior 20-pack-year smoking reported several days of fatigue to his primary care physician. His family was notable metastatic kidney cancer in father. On laboratory testing, he anemic (hemoglobin, 11.2 g/dL), with iron studies suggestive iron-deficiency anemia. He denied any melena, hematochezia, or hematuria underwent full workup, including colonoscopy capsule endoscopy, which were...

10.3322/caac.21835 article EN CA A Cancer Journal for Clinicians 2024-04-03

The presence of paraneoplastic syndromes (PNS) in patients with renal cell carcinoma (RCC) is associated worse survival; however, little known about whether resolution PNS after intervention has any prognostic value. We sought to determine if by one year cytoreductive nephrectomy was significantly improved overall survival (OS) and cancer-specific (CSS).

10.3390/cancers16213678 article EN Cancers 2024-10-30

Drain evaluation and management is an essential skill for practicing surgeons. There are a multitude of laboratory analyses that may assist in the elucidation drain fluid source. Our goal to review current biochemical available effort guide perioperative management. A PubMed search all English language literature analysis following urologic general surgeries was conducted. Further sources were identified reference lists articles. All relevant articles published reviewed used delineate...

10.1016/j.soi.2023.100001 article EN cc-by Surgical Oncology Insight 2023-11-17

The purpose of this review is to provide an up-to-date understanding the literature describing impact body composition on renal cell carcinoma (RCC) prognosis and outcomes. Although obesity recognized as a risk factor for RCC development, overweight patients with localized advanced display more favorable outcomes than normal-weight individuals. However, measured by mass index poor indicator total fat, fails account lean muscle mass, inconsistently predicts perioperative survival in RCC....

10.22465/juo.234600500025 article EN cc-by-nc Journal of Urologic Oncology 2023-11-28

IO9V. Study upon Luxations of the Interarticular Menisci Knee.By Dr. Braquehaye.Author collected from lit¬ erature subject sixteen observations these very rare luxations and added one new case.On basis his studies he reaches following conclusions: 1st, luxation may be external or inter¬ nal, corresponding to luxated meniscus anteriorly poste¬ riorly lateral ligaments.2d, in an anterior direction is most frequent; inward posterior rare.3d, occures only cases flexion knee, limbs being...

10.1097/00000658-189301000-00035 article EN Annals of Surgery 1893-01-01

You have accessJournal of UrologyKidney Cancer: Advanced (Including Drug Therapy) II (PD18)1 May 2024PD18-04 SURVIVAL IS DRAMATICALLY IMPROVED FOR MRCC PATIENTS WITH SARCOMATOID FEATURES WHO ARE TREATED CYTOREDUCTIVE NEPHRECTOMY AND IMMUNE CHECKPOINT INHIBITORS REGARDLESS OF TREATMENT SEQUENCE Daniel D. Shapiro, Jose A. Karam, Viraj Master, Philippe E. Spiess, Charles C. Peyton, Sarah P. Psutka, Jay Raman, Chiara Mercinelli, Edouard Nicaise, Nicholas Robertson, R. Barry Sirard, Amber Jani,...

10.1097/01.ju.0001008596.32809.c5.04 article EN The Journal of Urology 2024-04-15

You have accessJournal of UrologyKidney Cancer: Advanced (Including Drug Therapy) II (PD18)1 May 2024PD18-06 VALIDATION OF THE SELECTION FOR CYTOREDUCTIVE NEPHRECTOMY (SCREEN) MODEL USING AN INDEPENDENT CONTEMPORARY MULTI-CENTER COHORT E. Jason Abel, Viraj A. Master, Philippe Spiess, Charles C. Peyton, Sarah P. Psutka, Jay D. Raman, Chiara Mercinelli, Daniel Shapiro, Edouard Nicaise, Nicholas Robertson, Brendan K. Dolan, R. Barry Sirard, Meghana Noonavath, Amber Jani, Andrea Necchi, Wade J....

10.1097/01.ju.0001008596.32809.c5.06 article EN The Journal of Urology 2024-04-15

You have accessJournal of UrologyKidney Cancer: Epidemiology & Evaluation/Staging/Surveillance I (MP36)1 May 2024MP36-05 NODESAFE NOMOGRAM: A NOVEL SCORE SYSTEM TO PREDICT LYMPH NODE INVOLVEMENT AT THE TIME OF NEPHRECTOMY OR NODAL RECURRENCE IN NON-METASTATIC RENAL CELL CARCINOMA Cesare Saitta, Jonathan A. Afari, Mimi V. Nguyen, Kevin Hakimi, Dattatraya Patil, Hajime Tanaka, Julian Cortes, Jacob Roberts, Margaret F. Meagher, Franklin Liu, Mirha Mahmood, Joshua Matian, Mariam Mansour, Dhruv...

10.1097/01.ju.0001008612.93052.9d.05 article EN The Journal of Urology 2024-04-15

You have accessJournal of UrologyKidney Cancer: Advanced (including Drug Therapy) I (MP10)1 May 2024MP10-11 A PROPENSITY SCORE-MATCHED ANALYSIS OF OUTCOMES NEOADJUVANT AND ADJUVANT SYSTEMIC THERAPY IN HIGH-RISK LOCALIZED RENAL CELL CARCINOMA: IMPACT TIMING POSITIVE MARGIN Cesare Saitta, Mimi V. Nguyen, Kevin Hakimi, Dattatraya Patil, Hajime Tanaka, Jonathan A. Afari, Julian Cortes, Jacob Roberts, Margaret F. Meagher, Franklin Liu, Mirha Mahmood, Joshua Matian, Mariam Mansour, Dhruv Puri,...

10.1097/01.ju.0001008588.39303.c9.11 article EN The Journal of Urology 2024-04-15

You have accessJournal of UrologyStone Disease: Epidemiology & Evaluation II (MP45)1 May 2024MP45-20 THE ASSOCIATION BETWEEN PRESCRIPTION MEDICATIONS AND KIDNEY STONE PREVALENCE AMONG U.S. ADULTS Frank E. Glover, Kait F. Al, Jeremy P. Burton, Edouard H. Nicaise, Viraj Master, Kenneth Ogan, Albert Ha, Michael Scott, Francesco Del Giudice, Federico Belladelli, and L. Eisenberg GloverFrank Glover , AlKait Al BurtonJeremy Burton NicaiseEdouard Nicaise MasterViraj Master OganKenneth Ogan HaAlbert...

10.1097/01.ju.0001008764.86460.8e.20 article EN The Journal of Urology 2024-04-15
Coming Soon ...